Bellevue Funds (Lux) - Bellevue Diversified Healthcare I2 Acc CHF Fonds
|
ISIN: LU2441706921
Anlageziel
The investment objective of the sub-fund is to achieve long-term capital growth by investing at least two thirds of the net assets of Bellevue Diversified Healthcare in a portfolio of carefully chosen shares and preference shares of companies in the health sector or companies whose main activity involves holding investments in such companies or financing such companies and that have their registered office or carry out the majority of their economic activity in recognised countries. Without restricting the scope of the term “healthcare”, the healthcare sector includes companies from the pharmaceutical, medical technology, biotechnology and related sectors.
Stammdaten
WKN | |
ISIN | LU2441706921 |
Fondsgesellschaft | Bellevue Asset Management |
Kategorie | Branchen: Biotechnologie |
Währung | CHF |
Mindestanlage | |
VL-fähig? | Nein |
Thesaurierend/Ausschüttend | Thesaurierend |
Fondsmanager |
Aktuelle Daten
Fondsnote | - |
Aktueller Rücknahmepreis | 127,29 |
Fondsvolumen | 22 895 318,34 |
Total Expense Ratio (TER) | 1,28 |
Gebühren
Verwaltungsgebühr | % |
Depotbankgebühr | % |
Rücknahmegebühr | % |
Ausgabeaufschlag | % |
Basisdaten
Auflagedatum | 31.03.2022 |
Depotbank | CACEIS Bank, Luxembourg Branch |
Zahlstelle | |
Domizil | Luxembourg |
Geschäftsjahr | 30.06.2025 |
Performancedaten
Veränderung Vortag | -0,12 |